India's Pharma and Life Sciences Hiring Requests Rise 20 Percent as Firms Seek Specialized Talent

Hiring requests from India's pharmaceutical and life sciences sector climbed 20 percent between April and September this year, with mid-career professionals accounting for 60 percent of the demand, according to a report by staffing firm Spectrum Talent Management. The findings, released this week, describe a market in which employers are chasing specific technical skills rather than adding headcount broadly.

Professionals with four to eight years of experience generated most of the demand. The report lists regulatory affairs, data analytics, artificial intelligence and machine learning, operational excellence, complex generic research and development, supply chain and global capability centers among the main drivers of hiring.

Policy push behind the demand

The shift tracks a strong policy push to invest in India's pharmaceutical manufacturing and research base, the report said. The government's production-linked incentive scheme for pharmaceuticals has attracted Rs 46,744 crore and created more than 1.21 lakh jobs as of June 2026. A separate scheme for bulk drugs has commissioned 39 projects covering 28 active pharmaceutical ingredients and key starting materials.

Spectrum Talent Management chief executive Atanu Banerjee said the sector is moving from adding capacity to adding capability. Companies are increasingly turning to contract and flexible talent for specialized needs while continuing to hire permanent staff for core roles, he said.

What it means for careers

For working professionals, the data suggests that mid-career moves carry the most opportunity, particularly for those whose skills sit at the meeting point of science and digital operations. Regulatory affairs and data analytics appear alongside AI/ML in the list of demand areas, indicating that employers want people who can handle compliance and evidence as well as technical systems.

The emphasis on global capability centers also points to a hiring route that differs from traditional plant or laboratory roles. These centers handle work for international parent organizations, and the report places them among the drivers of demand, alongside supply chain and operational excellence.

The report's attention to complex generic research reflects the segment where Indian manufacturers have built much of their export business. Skills tied to formulation development and regulatory filing for generic products therefore remain relevant even as demand grows for digital and analytical capabilities.

Skills and the wider workforce

The findings arrive as pharmaceutical manufacturing expands under a policy framework designed to reduce dependence on imported inputs and build domestic research capacity. The bulk drugs scheme, with its 39 commissioned projects across 28 ingredients, is aimed at strengthening the supply base that formulators and manufacturers rely on.

Employment growth of this kind creates demand for training that spans drug development, quality and regulatory work. The report does not give a state-by-state or city-level breakdown, nor does it specify how many of the hiring requests converted into confirmed appointments, so the 20 percent figure should be read as a measure of employer demand rather than of net job creation.

What to watch next is whether the demand for mid-career specialists holds through the second half of the fiscal year, and whether flexible and contract hiring continues to grow faster than permanent recruitment. The report also leaves open how quickly the jobs created under the incentive schemes translate into roles for graduates entering the sector, a question that will matter as the government weighs further investment in manufacturing and research capacity.